Crescent Biopharma (CBIO) Return on Sales [ROS] (2013 - 2026)
Crescent Biopharma (CBIO) reported Return on Sales [ROS] of -16214.63% for Q2 2026, down 13834.55 percentage points from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Return on Sales [ROS] (2013 - 2026) Analysis & Trends
For FY2025, Crescent Biopharma posted Return on Sales [ROS] of -1407.52%.
- Return on Sales [ROS] has a five-year change of -900.69 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -392752.93% in FY2023 (-329548.50 pp), -63204.43% in FY2022 (-57733.74 pp) and -5470.69% in FY2021 (-4963.85 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Sales [ROS] since Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | Crescent Biopharma | 395.80 Mn | -311.49 Mn | - | -16,214.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16,214.63% |
| Mar 31, 2026 | -2,380.08% |
| Dec 31, 2024 | -66,530.03% |
| Dec 31, 2022 | -51,177.67% |
| Sep 30, 2022 | -30,251.74% |
| Jun 30, 2022 | -17,804.21% |
| Dec 31, 2021 | -98,870.20% |
| Sep 30, 2021 | -20,028.82% |
| Jun 30, 2021 | -10,144,001.41% |
| Mar 31, 2021 | -1,352.98% |
| Dec 31, 2020 | -9,554.94% |
| Sep 30, 2020 | -1,372.73% |
| Jun 30, 2020 | -573.93% |
| Mar 31, 2020 | -90.09% |
| Sep 30, 2017 | -177,052.37% |
| Jun 30, 2017 | -60,250.04% |
| Mar 31, 2017 | -59,970.70% |
| Sep 30, 2016 | -42,631.11% |
| Dec 31, 2015 | -25,123.75% |
| Mar 31, 2015 | -87.48% |
API Access
Crescent Biopharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();